vinblastine has been researched along with paclitaxel in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.50) | 18.2507 |
2000's | 40 (50.00) | 29.6817 |
2010's | 38 (47.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
Baeuerle, PA; Baichwal, V; Beckmann, H; Case, C; Clark, DL; Farrell, RP; Jaen, JC; Learned, RM; Li, A; Medina, JC; Roche, D; Rosen, T; Shan, B | 1 |
Hargrove, P; Kim, RB; Lan, LB; Lecureur, V; Schuetz, EG; Schuetz, JD; Sun, D | 1 |
Corbett, TH; Edelstein, M; Hazeldine, ST; Horwitz, JP; Kushner, J; Palomino, E; Paluch, J; Polin, L; White, K | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 2 |
Barr, KJ; Claiborne, A; Credo, RB; Fitzgerald, M; Frost, D; Gehrke, L; Gwaltney, SL; Hui, YH; Kim, KH; Kovar, P; Lee, J; Li, Q; Liu, G; Marsh, K; Ng, SC; Nukkala, MA; Rosenberg, S; Sham, HL; Tahir, SK; Warner, RB; Woods, KW; Zielinski, NA | 1 |
Thakker, DR; Troutman, MD | 1 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Gibbons, S; Kaatz, GW; Zloh, M | 1 |
Bacherikov, VA; Chen, CH; Chou, TC; Dong, HJ; Lin, YW; Su, TL; Tsai, TJ | 1 |
Beney, C; Boumendjel, A; Deka, N; Dumontet, C; Hadjeri, M; Lawson, MA; Peiller, EL | 1 |
Attardo, G; Blais, C; Bouffard, D; Cai, SX; Denis, R; Drewe, J; Gourdeau, H; Herich, J; Jia, S; Jiang, S; Kasibhatla, S; Kemnitzer, W; Labreque, D; Lamothe, S; Meerovitch, K; Rej, R; Storer, R; Tseng, B; Wang, Y; Zhang, H; Zhao, J | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Bacherikov, VA; Chen, CH; Chou, TC; Lin, YW; Liu, LF; Su, TL; Tsai, TJ; Zhang, X | 1 |
Aspland, SE; Ballatore, C; Castellino, AJ; Castillo, R; Desharnais, J; Eustaquio, T; Goelet, P; Guo, Z; Li, Q; Nelson, D; Newman, MJ; Sun, C | 1 |
Burkett, BA; Chan, KF; Chan, TH; Chow, LM; Wong, IL; Zhao, Y | 1 |
Cai, X; Duan, JX; Hart, C; Lan, L; Matteucci, M; Meng, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
C-Gaudreault, R; Desjardins, M; Fortin, JS; Lacroix, J; Patenaude, A; Petitclerc, E | 1 |
Copper, JE; Gangjee, A; Smith, CD; Yu, J | 1 |
Bremner, JB; Locke, JM; Pyne, SG; Ranson, M; Vine, KL | 1 |
Henriquez, FL; Ingram, PR; Muench, SP; Rice, DW; Roberts, CW | 1 |
Andriantsiferana, R; Birkinshaw, C; Brodie, P; Kingston, DG; Miller, JS; Murphy, BT; Randrianjanaka, LM; Rasamison, VE; Slebodnick, C; Suh, EM; TenDyke, K | 1 |
Attardo, G; Bubenick, M; Cai, SX; Crogan-Grundy, C; Denis, R; Drewe, J; Gourdeau, H; Jiang, S; Kasibhatla, S; Kemnitzer, W; Labreque, D; Lamothe, S; Tseng, B; Zhang, H | 1 |
Chen, GY; Fong, WF; Globisch, C; Hu, YJ; Shen, XL; Tse, AK; Wiese, M; Yu, ZL; Zhu, GY | 1 |
Barraja, P; Basso, G; Cirrincione, G; Dall'acqua, F; Dattolo, G; Diana, P; Martorana, A; Montalbano, A; Salvador, A; Vedaldi, D; Viola, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, YT; Chou, TC; Kakadiya, R; Kapuriya, K; Kapuriya, N; Lee, TC; Naliapara, Y; Shah, A; Su, TL; Tsai, TH; Wu, YT; Zhang, X | 1 |
Fong, WF; Fu, LC; Hu, YJ; Huang, XA; Lu, HL; Shen, XL; Zhang, YH | 1 |
C-Gaudreault, R; Côté, MF; Fortin, JS; Lacroix, J; Petitclerc, E | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, YT; Chou, TC; Dong, H; Kapuriya, K; Kapuriya, N; Lee, TC; Lee, WC; Naliapara, Y; Su, TL; Tsai, TH; Zhang, X | 1 |
Cai, SX; Crogan-Grundy, C; Drewe, J; May, C; Tseng, B; Zhang, HZ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cai, SX; Crogan-Grundy, C; Drewe, J; Jiang, S; Kasibhatla, S; Kemnitzer, W; Kuemmerle, J; Sirisoma, N; Tseng, B | 1 |
Cai, SX; Drewe, J; Kasibhatla, S; Kemnitzer, W; Kuemmerle, J; Tseng, B; Zhang, HZ | 1 |
Chou, TC; Dong, H; Kakadiya, R; Kapuriya, K; Kapuriya, N; Lee, PC; Lee, TC; Shah, A; Su, TL; Zhang, X | 1 |
Bochenek, D; Gogler, A; Gruca, A; Grynkiewicz, G; Głowala-Kosińska, M; Krawczyk, Z; Rusin, A; Szeja, W; Zawisza, J | 1 |
Bernard, P; Do, QT; Galmarini, CM; Joseph, B; Kozielski, F; Popowycz, F; Putey, A; Talapatra, SK | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cai, SX; Crogan-Grundy, C; Drewe, J; Jiang, S; Kasibhatla, S; Kemnitzer, W; Sirisoma, N; Tseng, B | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Chou, TC; Dong, H; Kakadiya, R; Kumar, A; Lee, TC; Narsinh, D; Shah, A; Su, TL; Zhang, X | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
Chen, J; Dalton, JT; Li, CM; Li, W; Lu, Y; Meibohm, B; Miller, DD; Vaddady, PK; Wang, Z | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Chen, CH; Chou, TC; Dong, H; Kakadiya, R; Kapuriya, N; Kumar, A; Lam, K; Lee, PC; Lee, TC; Marvania, B; Shah, A; Su, TL; Zhang, X | 1 |
Chaniyara, R; Chou, TC; Dong, H; Kakadiya, R; Kapuriya, N; Lee, PC; Lee, TC; Marvania, B; Shah, A; Su, TL; Suman, S | 1 |
Carlson, EM; Cheng, H; Du, H; Hu, Y; Jiang, Y; Lewis, BM; Littlefield, BA; Narayan, S; Seletsky, BM; Tendyke, K; Towle, MJ; Yu, MJ; Zhang, H; Zheng, W | 1 |
Carlson, EM; Cheng, H; Condon, K; Du, H; Eckley, S; Hu, Y; Jiang, Y; Kumar, V; Lewis, BM; Littlefield, BA; Narayan, S; Saxton, P; Schuck, E; Seletsky, BM; Tendyke, K; Towle, MJ; Yu, MJ; Zhang, H; Zheng, W | 1 |
Chaniyara, R; Chou, TC; Dong, H; Kakadiya, R; Lee, PC; Lee, TC; Marvania, B; Shah, A; Su, TL; Suman, S | 1 |
Chen, J; Dalton, JT; Li, CM; Li, W; Lu, Y; Miller, DD; Mohler, ML; Wang, Z | 1 |
C-Gaudreault, R; Côté, MF; Fortin, S; Kotra, LP; Lacroix, J; Moreau, E; Petitclerc, E; Wei, L | 1 |
Baraldi, PG; Basso, G; Bortolozzi, R; Brancale, A; Hamel, E; Ricci, A; Romagnoli, R; Viola, G | 1 |
Gangjee, A; Keller, SN; Namjoshi, OA; Smith, CD | 1 |
Chalmers, DK; Chaplin, JH; Charman, SA; Flynn, BL; Gill, GS; Grobelny, DW; Hamel, E; Jung, MK; Kostewicz, E; Kremmidiotis, G; Lavranos, TC; Leske, AF; Morizzi, J; Paul, D; Shackleford, DM | 1 |
Côté, MF; Fortin, S; Gaudreault, RC; Kotra, LP; Lacroix, J; Moreau, E; Petitclerc, E; Wei, L | 1 |
Balzarini, J; Baraldi, PG; Basso, G; Bortolozzi, R; Brancale, A; Fu, XH; Hamel, E; Kimatrai Salvador, M; Li, J; Lopez Cara, C; Romagnoli, R; Viola, G; Zhang, SZ | 1 |
Bai, R; Bolognesi, A; Brancale, A; Coluccia, A; Dondio, G; Ferlini, C; Gatti, V; Granata, I; Hamel, E; Iannitto, ML; La Regina, G; Lavecchia, A; Lavia, P; Maresca, B; Mariani, M; Mercurio, C; Novellino, E; Piscitelli, F; Porta, A; Rensen, W; Santoni, A; Silvestri, R; Soriani, A; Varasi, M | 1 |
Delva, D; Ode, E; Patel, M; Shimada, K; Skouta, R; Stockwell, BR; Yang, WS | 1 |
Chaniyara, R; Chen, CH; Chen, CW; Chou, TC; Dong, H; Kakadiya, R; Lee, PC; Lee, TC; Marvania, B; Shah, A; Su, TL; Tala, S | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Lama, R; Li, B; Sandhu, R; Su, B; Zhong, B | 1 |
Baraldi, PG; Bassetto, M; Basso, G; Bortolozzi, R; Brancale, A; Camacho, ME; Hamel, E; Preti, D; Romagnoli, R; Salvador, MK; Tabrizi, MA; Viola, G | 1 |
Bai, R; Brancale, A; Chen, F; Coluccia, A; Costa, B; Da Pozzo, E; Di Cesare, E; Dondio, G; Famiglini, V; Granata, I; Hamel, E; Iannitto, ML; La Regina, G; Lavia, P; Li, J; Maresca, B; Martini, C; Mercurio, C; Miranda Cona, M; Nalli, M; Ni, Y; Novellino, E; Pelliccia, S; Piscitelli, F; Porta, A; Reggio, A; Rensen, WM; Santoni, A; Silvestri, R; Soriani, A; Varasi, M; Vultaggio, S | 1 |
Aghazadeh Tabrizi, M; Baraldi, PG; Bassetto, M; Basso, G; Bortolozzi, R; Brancale, A; Castagliuolo, I; Hamel, E; Kimatrai Salvador, M; Preti, D; Romagnoli, R; Viola, G | 1 |
Ahn, S; Chen, J; Dalton, JT; Li, W; Miller, DD; Wang, J; Xiao, M | 1 |
Brodie, PJ; Dai, Y; Goetz, M; Harinantenaina, L; Kingston, DG; Shen, Y; TenDyke, K | 1 |
Avery, VM; Sykes, ML | 1 |
Banuls, LM; Betancourt, T; Evdokimov, NM; Frolova, LV; Hamel, E; Hayden, K; Karki, M; Kiss, R; Kornienko, A; Lu, SL; Magedov, IV; Otero, I; Rastogi, SK; Rogelj, S; Romero, AE; Shuster, CB; Smith, WR | 1 |
Alfonsi, R; Bai, R; Bolognesi, A; Brancale, A; Coluccia, A; Di Marcotullio, L; Dondio, G; Famiglini, V; Gulino, A; Hamel, E; La Regina, G; Lavia, P; Mazzoccoli, C; Mercurio, C; Miele, A; Nalli, M; Novellino, E; Passacantilli, S; Pelliccia, S; Rensen, WM; Ruggieri, V; Silvestri, R; Sisinni, L; Varasi, M; Vultaggio, S | 1 |
Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV | 1 |
Aksenov, AV; Aksenov, NA; Aksenova, IV; Brenner, AJ; Bryan, BA; Cavazos, DA; Correa, J; De Carvalho, A; Frolova, LV; Johnston, RK; Kiss, R; Kornienko, A; Lefranc, F; Magedov, IV; Mathieu, V; Nguyen, G; Pendleton, AL; Reisenauer, MR; Rogelj, S; Rubin, M; Smirnov, AN | 1 |
Li, S; Li, Z; Meng, X; Pan, L; Su, B; Yang, S; Yu, S; Zhang, C; Zhong, B | 1 |
Alfonsi, R; Bai, R; Bigogno, C; Brancale, A; Caraglia, M; Coluccia, A; Da Pozzo, E; Di Marcotullio, L; Dondio, G; Famiglini, V; Gulino, A; Hamel, E; La Regina, G; Lavia, P; Marinelli, L; Martini, C; Mazzoccoli, C; Mercurio, C; Miele, A; Monti, L; Nalli, M; Novellino, E; Passacantilli, S; Pelliccia, S; Porto, S; Ricci, B; Ruggieri, V; Santoni, A; Silvestri, R; Soriani, A; Varasi, M; Verrico, A; Vultaggio, S | 1 |
Burth, P; Calixto, JB; Dasari, R; De Carvalho, A; De La Chapa, JJ; Dybdal-Hargreaves, NF; Evidente, A; Frolova, LV; Gautier, M; Glass, R; Gonzales, CB; Hague, F; Kälin, RE; Kiss, R; Kornienko, A; Mathieu, V; Medellin, DC; Middleton, KN; Munirathinam, G; Pelly, SC; Pillai, A; Rogelj, S; Rossato, MF; van Otterlo, WA; Volmar, MN | 1 |
2 review(s) available for vinblastine and paclitaxel
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
78 other study(ies) available for vinblastine and paclitaxel
Article | Year |
---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Novel antineoplastic agents with efficacy against multidrug resistant tumor cells.
Topics: Antineoplastic Agents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorobenzenes; Humans; Phenotype; Sulfonamides; Tumor Cells, Cultured | 1998 |
Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein.
Topics: Amino Acid Sequence; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Cells, Cultured; Cloning, Molecular; DNA, Complementary; Humans; Karyotyping; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Sequence Homology, Amino Acid | 2000 |
Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).
Topics: Animals; Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Quinoxalines; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent.
Topics: Animals; Antineoplastic Agents; Biological Availability; Drug Screening Assays, Antitumor; Humans; Indoles; Mice; Microtubules; Models, Molecular; Oxazoles; Polymers; Rats; Stereoisomerism; Tubulin; Tumor Cells, Cultured | 2002 |
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans | 2003 |
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular | 2004 |
Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation.
Topics: Amsacrine; Animals; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Injections, Intravenous; Mice; Mice, Nude; Nitrogen Mustard Compounds; Paclitaxel; Structure-Activity Relationship; Tumor Cells, Cultured; Vinblastine; Xenograft Model Antitumor Assays | 2004 |
Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones.
Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; G2 Phase; Humans; K562 Cells; Mitosis; Quinolones; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles | 2004 |
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Topics: Antineoplastic Agents; Apoptosis; Benzopyrans; Biopolymers; Caspases; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Dioxoles; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship; Tubulin | 2004 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
Topics: Acridines; Aminoacridines; Aniline Compounds; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; DNA; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Nitrogen Mustard Compounds; Structure-Activity Relationship; Transplantation, Heterologous | 2006 |
Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Drug Design; Humans; Microtubules; Neoplasm Proteins; Neoplasms; Paclitaxel; Protein Kinases; Structure-Activity Relationship; Substrate Specificity; Thymidine; Vinblastine | 2006 |
Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Apigenin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Dimerization; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Paclitaxel; Polyethylene Glycols; Structure-Activity Relationship; Vinblastine | 2006 |
Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Topics: Acetylene; Animals; Binding Sites; Binding, Competitive; Cattle; Cell Line, Tumor; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Indazoles; Radioligand Assay; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
Topics: Antineoplastic Agents, Alkylating; Binding Sites; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; HT29 Cells; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Protein Binding; Proteins; Structure-Activity Relationship; Substrate Specificity; Tubulin; Urea | 2007 |
Discovery of novel antitumor antimitotic agents that also reverse tumor resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cattle; Cell Cycle; Cell Line, Tumor; Colchicine; Drug Resistance, Neoplasm; Humans; Magnetic Resonance Spectroscopy; Mitosis; Tubulin; Vinblastine | 2007 |
An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.
Topics: Antineoplastic Agents; Apoptosis; Biopolymers; Caspase 3; Caspase 7; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Isatin; Lymphocytes; Microtubules; Stereoisomerism; Structure-Activity Relationship; Tubulin | 2007 |
Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.
Topics: Acanthamoeba; Acanthamoeba castellanii; Albendazole; Animals; Binding Sites; Colchicine; Dinitrobenzenes; Drug Resistance; Models, Molecular; Paclitaxel; Parasitic Sensitivity Tests; Sulfanilamides; Tubulin; Tubulin Modulators; Vinblastine | 2008 |
Antiproliferative limonoids of a Malleastrum sp. from the Madagascar rainforest.
Topics: Antineoplastic Agents, Phytogenic; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Limonins; Madagascar; Molecular Conformation; Molecular Structure | 2008 |
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions.
Topics: Antineoplastic Agents; Apoptosis; Benzopyrans; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Indoles; Pyrroles; Structure-Activity Relationship; Tubulin Modulators | 2008 |
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Coumarins; Drug Resistance, Multiple; Humans; Molecular Structure; Neoplasms; Oxygen; Pyranocoumarins; Pyrans; Sensitivity and Specificity; Structure-Activity Relationship; Substrate Specificity | 2008 |
Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I.
Topics: Antineoplastic Agents; Caspases; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Magnetic Resonance Spectroscopy; Microscopy, Fluorescence; Mitosis; Polymers; Quinoxalines; Reactive Oxygen Species; Spectrophotometry, Infrared; Topoisomerase I Inhibitors; Tubulin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
Topics: Acridines; Amsacrine; Aniline Mustard; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Molecular Structure; Rats; Stereoisomerism; Urea; Xenograft Model Antitumor Assays | 2008 |
Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Marsdenia; Multidrug Resistance-Associated Proteins; Paclitaxel; Plants, Medicinal; Puromycin; Steroids; Vinblastine | 2008 |
Aromatic 2-chloroethyl urea derivatives and bioisosteres. Part 2: Cytocidal activity and effects on the nuclear translocation of thioredoxin-1, and the cell cycle progression.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Humans; Molecular Structure; Structure-Activity Relationship; Thioredoxins; Urea | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Novel DNA-directed alkylating agents: design, synthesis and potent antitumor effect of phenyl N-mustard-9-anilinoacridine conjugates via a carbamate or carbonate linker.
Topics: Acridines; Animals; Antineoplastic Agents, Alkylating; Carbamates; Carbonates; Cell Line, Tumor; DNA; Dose-Response Relationship, Drug; Drug Design; Half-Life; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Nude; Neoplasms; Rats; Xenograft Model Antitumor Assays | 2009 |
Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Line, Tumor; Drug Discovery; Drug Screening Assays, Antitumor; Guanidines; Humans; Semicarbazides; Structure-Activity Relationship; Tubulin Modulators | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Quinolines; Structure-Activity Relationship | 2009 |
Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chemistry, Pharmaceutical; Combinatorial Chemistry Techniques; Drug Design; Drug Evaluation, Preclinical; Humans; Infusions, Intravenous; Mice; Models, Chemical; Molecular Structure; Neoplasm Transplantation; Oxadiazoles; Solubility; Structure-Activity Relationship; Water | 2009 |
Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes.
Topics: Animals; Antineoplastic Agents, Alkylating; Aza Compounds; Breast Neoplasms; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Cross-Linking Reagents; DNA; Female; Humans; Indenes; Mice; Mice, Nude; Neoplasms; Remission Induction; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
Unsaturated genistein disaccharide glycoside as a novel agent affecting microtubules.
Topics: Antineoplastic Agents; Cell Line, Tumor; Disaccharides; Genistein; Glycosides; Humans; Microtubules; Tubulin Modulators | 2009 |
Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies.
Topics: Antineoplastic Agents; Benzazepines; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Indoles; Structure-Activity Relationship; Tubulin Modulators | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 9-oxo-9H-fluorene ring.
Topics: Amides; Antineoplastic Agents; Apoptosis; Caspases; Drug Discovery; Fluorenes; HCT116 Cells; High-Throughput Screening Assays; Humans; Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Potent DNA-directed alkylating agents: Synthesis and biological activity of phenyl N-mustard-quinoline conjugates having a urea or hydrazinecarboxamide linker.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Humans; Hydrazines; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Quinolines; Rats; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Urea | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.
Topics: Animals; Binding Sites; Cell Line, Tumor; Colchicine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Imidazoles; Mice; Mice, Inbred C57BL; Models, Molecular; Neoplasm Transplantation; Protein Binding; Protein Multimerization; Solubility; Structure-Activity Relationship; Transplantation, Heterologous; Tubulin; Tubulin Modulators | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Design, synthesis, and biological evaluation of novel water-soluble N-mustards as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Limit of Detection; Male; Mice; Mice, Nude; Mustard Compounds; Rats; Rats, Sprague-Dawley; Solubility; Water; Xenograft Model Antitumor Assays | 2011 |
Novel bifunctional alkylating agents, 5,10-dihydropyrrolo[1,2-b]isoquinoline derivatives, synthesis and biological activity.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Cycle; Cell Line, Tumor; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2011 |
Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Line, Tumor; Furans; Humans; Ketones; Mice; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2011 |
Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Drug Resistance, Neoplasm; Furans; Humans; Ketones; Mice; Mice, Inbred BALB C; Xenograft Model Antitumor Assays | 2011 |
Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Humans; Mice; Mice, Nude; Mustard Plant; Neoplasms; Quinazolines; Structure-Activity Relationship; Urea; Xenograft Model Antitumor Assays | 2011 |
Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents.
Topics: Administration, Oral; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cattle; Cell Line, Tumor; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Rats; Rats, Sprague-Dawley; Solubility; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Tubulin; Tubulin Modulators | 2011 |
Design, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4.
Topics: Angiogenesis Inhibitors; Animals; Arylsulfonates; Benzene Derivatives; Binding Sites; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Colchicine; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazolidines; Models, Molecular; Molecular Mimicry; Neovascularization, Physiologic; Quantitative Structure-Activity Relationship; Stilbenes; Transplantation, Heterologous; Tubulin Modulators | 2011 |
Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agents.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Microtubules; Mitosis; Models, Molecular; Protein Binding; Structure-Activity Relationship; Thiazoles; Tubulin Modulators | 2011 |
2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mitosis; Molecular Structure; Pyrimidines; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2011 |
Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
Topics: Anisoles; Aorta; Benzofurans; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Humans; Neovascularization, Physiologic; Structure-Activity Relationship; Tubulin Modulators | 2011 |
Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships.
Topics: Angiogenesis Inhibitors; Animals; Antimitotic Agents; Benzenesulfonamides; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Colchicine; Humans; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship; Sulfonamides; Xenograft Model Antitumor Assays | 2011 |
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agent.
Topics: Animals; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cell Proliferation; Female; G2 Phase; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Thiazoles; Tubulin; Tubulin Modulators | 2011 |
Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Caspase 3; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Furans; Humans; In Vitro Techniques; Indoles; Injections, Intravenous; Male; Mice; Mice, Nude; Microsomes, Liver; Pyrroles; Solubility; Structure-Activity Relationship; Thiophenes; Tubulin Modulators | 2011 |
Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency.
Topics: | 2012 |
Synthesis and antitumor evaluation of novel benzo[d]pyrrolo[2,1-b]thiazole derivatives.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; DNA; Humans; Inhibitory Concentration 50; Male; Mice; Thiazoles; Xenograft Model Antitumor Assays | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Identification of selective tubulin inhibitors as potential anti-trypanosomal agents.
Topics: Amino Acid Sequence; Animals; Cattle; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Models, Molecular; Molecular Sequence Data; Structural Homology, Protein; Sulfonamides; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African; Tubulin; Tubulin Modulators | 2012 |
Synthesis and biological evaluation of 2-substituted-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colchicine; HeLa Cells; Humans; Microtubules; Models, Molecular; Structure-Activity Relationship; Thiazoles; Tubulin | 2012 |
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indoles; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Microsomes, Liver; Mitosis; Permeability; Polymerization; Pyridines; Reactive Oxygen Species; Rhabdomyosarcoma; Solubility; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2013 |
Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b]pyridines as new potent anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Colchicine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lymphocytes; Mice; Mitochondria; Models, Molecular; Protein Multimerization; Protein Structure, Quaternary; Pyridines; Thiophenes; Tubulin; Xenograft Model Antitumor Assays | 2013 |
Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative properties.
Topics: Cell Line, Tumor; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazoles; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2013 |
Antiproliferative Homoisoflavonoids and Bufatrienolides from Urginea depressa.
Topics: Antineoplastic Agents, Phytogenic; Drimia; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Isoflavones; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Steroids | 2013 |
Exploring natural product chemistry and biology with multicomponent reactions. 5. Discovery of a novel tubulin-targeting scaffold derived from the rigidin family of marine alkaloids.
Topics: Alkaloids; Biological Products; Colchicine; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Tubulin | 2013 |
New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Colchicine; Drug Screening Assays, Antitumor; Guanidines; Hedgehog Proteins; Humans; M Phase Cell Cycle Checkpoints; Mice; Molecular Docking Simulation; Neoplasms; Polymerization; Protein Binding; Pyrroles; Signal Transduction; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2014 |
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2015 |
Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.
Topics: Antineoplastic Agents; Cell Differentiation; Cells, Cultured; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fibroblasts; Humans; Hydroxamic Acids; Indoles; Neoplasms; Neoplastic Stem Cells; Structure-Activity Relationship | 2015 |
Synthesis and biological evaluation of thiabendazole derivatives as anti-angiogenesis and vascular disrupting agents.
Topics: Angiogenesis Inhibitors; Anthelmintics; Cell Proliferation; Drug Repositioning; HCT116 Cells; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Structure-Activity Relationship; Thiabendazole; Tubulin; Tubulin Modulators | 2015 |
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer.
Topics: Animals; Cell Division; Cell Line, Tumor; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Hedgehog Proteins; Humans; Indoles; Killer Cells, Natural; Mice; Mitosis; Neoplasms; NIH 3T3 Cells; Tubulin | 2015 |
Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines.
Topics: Amines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Polygonum; Pyrroles; Sesquiterpenes; Structure-Activity Relationship | 2015 |